Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors
Type
Published Article
Journal
Journal of Neurochemistry
1471-4159
Publisher
Wiley Blackwell (Blackwell Publishing)
Publication Date
Volume
133
Issue
2
Pages
266–272
Identifiers
DOI: 10.1111/jnc.12960
PMID: 25279694
Source
Medline
Keywords
  • Alzheimer'S Disease
  • Sp1
  • Cyclin-Dependent Kinase-5
  • Tau
  • Therapy
  • Tolfenamic Acid

Abstract

Statistics

Seen <100 times